Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

IDH2 mutation + Chr del(1p) + Chr del(19q) (9)

EML4-ALK + ALK G1202R + LIPI-NTRK1 (2)

IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion (2)

IDH1 mutation + NTRK1 fusion (2)

IDH2 mutation + NTRK1 fusion (2)

NCOR2-NTRK1 fusion + TMB-H (2)

IDH2 mutation + BRAF V600E (2)

IDH2 mutation + Chr del(1p) + Chr del(19q) + BRAF V600E (2)

IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK2 fusion (2)

IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK3 fusion (2)

IDH2 mutation + NTRK2 fusion (2)

IDH2 mutation + NTRK3 fusion (2)

MYC overexpression + IDH2 mutation (2)

EGFR exon 19 deletion + LMNA-NTRK1 fusion + EGFR T790M (1)

LMNA-NTRK1 fusion + NTRK1 G595R (1)

MSI-H/dMMR + NTRK1 fusion (1)

NOTCH2-NTRK1 fusion + EGFR L858R (1)

SQSTM1-NTRK1 + PIK3CA E545K + TP53 L145R + PD-L1 overexpression (1)

TPM3-NTRK1 fusion + ALK L1196M (1)

BAP1 mutation + IDH2 R172W + CDKN2A deletion + CDKN2B deletion (1)

IDH wild-type + FGFR3 S249C + TP53 V73fs (1)

IDH2 mutation + ALK fusion (1)

IDH2 mutation + MGMT promoter methylation (1)

IDH2 mutation + MYC amplification + MAPRE1 overexpression (1)

IDH2 mutation + TMB-L (1)

PIK3CA mutation + IDH2 mutation + Chr del(1q) + Chr del(17) (1)

PIK3CA mutation + TTN mutation + IDH2 mutation + Chr del(1q) + Chr del(17) (1)

IDH2 mutation + Chr del(1p) + Chr del(19q) + MGMT promoter methylation (0)

IDH2 mutation + Chr del(1p) + Chr del(19q) (9)

EML4-ALK + ALK G1202R + LIPI-NTRK1 (2)

IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion (2)

IDH1 mutation + NTRK1 fusion (2)

IDH2 mutation + NTRK1 fusion (2)

NCOR2-NTRK1 fusion + TMB-H (2)

IDH2 mutation + BRAF V600E (2)

IDH2 mutation + Chr del(1p) + Chr del(19q) + BRAF V600E (2)

IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK2 fusion (2)

IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK3 fusion (2)

IDH2 mutation + NTRK2 fusion (2)

IDH2 mutation + NTRK3 fusion (2)

MYC overexpression + IDH2 mutation (2)

EGFR exon 19 deletion + LMNA-NTRK1 fusion + EGFR T790M (1)

LMNA-NTRK1 fusion + NTRK1 G595R (1)

MSI-H/dMMR + NTRK1 fusion (1)

NOTCH2-NTRK1 fusion + EGFR L858R (1)

SQSTM1-NTRK1 + PIK3CA E545K + TP53 L145R + PD-L1 overexpression (1)

TPM3-NTRK1 fusion + ALK L1196M (1)

BAP1 mutation + IDH2 R172W + CDKN2A deletion + CDKN2B deletion (1)

IDH wild-type + FGFR3 S249C + TP53 V73fs (1)

IDH2 mutation + ALK fusion (1)

IDH2 mutation + MGMT promoter methylation (1)

IDH2 mutation + MYC amplification + MAPRE1 overexpression (1)

IDH2 mutation + TMB-L (1)

PIK3CA mutation + IDH2 mutation + Chr del(1q) + Chr del(17) (1)

PIK3CA mutation + TTN mutation + IDH2 mutation + Chr del(1q) + Chr del(17) (1)

IDH2 mutation + Chr del(1p) + Chr del(19q) + MGMT promoter methylation (0)

›

IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion	Oligodendroglioma	IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion	Oligodendroglioma	entrectinib Sensitive: A2 - Guideline entrectinib Sensitive : A2	entrectinib Sensitive: A2 - Guideline entrectinib Sensitive : A2
IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion	Oligodendroglioma	IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion	Oligodendroglioma	larotrectinib Sensitive: A2 - Guideline larotrectinib Sensitive : A2	larotrectinib Sensitive: A2 - Guideline larotrectinib Sensitive : A2